ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Alabama » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in Alabama

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL KENDRICK MD

Interventional Pain Medicine

12,929

$1.21M

748
206 are 65+

59%
patients receiving schedule two controlled substances

Avg: 38%

53%
patients receiving schedule three controlled substances

Avg: 52%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

21%
prescriptions for brand name drugs

Avg: 18%

$94
Average prescription price

Avg: $64

RODDIE GANTT MD

Interventional Pain Medicine

12,200

$581K

797
289 are 65+

49%
patients receiving schedule two controlled substances

Avg: 38%

68%
patients receiving schedule three controlled substances

Avg: 52%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

8%
prescriptions for brand name drugs

Avg: 18%

$48
Average prescription price

Avg: $64

MICHAEL GIBSON M.D.

Interventional Pain Medicine

10,608

$1.29M

577
167 are 65+

66%
patients receiving schedule two controlled substances

Avg: 38%

46%
patients receiving schedule three controlled substances

Avg: 52%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

25%
prescriptions for brand name drugs

Avg: 18%

$121
Average prescription price

Avg: $64

MORRIS SCHERLIS MD

Interventional Pain Medicine

9,962

$363K

758
275 are 65+

35%
patients receiving schedule two controlled substances

Avg: 38%

73%
patients receiving schedule three controlled substances

Avg: 52%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

10%
prescriptions for brand name drugs

Avg: 18%

$36
Average prescription price

Avg: $64

RONALD COLLINS MD

Interventional Pain Medicine

8,653

$404K

698
289 are 65+

46%
patients receiving schedule two controlled substances

Avg: 38%

61%
patients receiving schedule three controlled substances

Avg: 52%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

12%
prescriptions for brand name drugs

Avg: 18%

$47
Average prescription price

Avg: $64

DAVID COSGROVE MD

Interventional Pain Medicine

8,303

$555K

531
151 are 65+

53%
patients receiving schedule two controlled substances

Avg: 38%

53%
patients receiving schedule three controlled substances

Avg: 52%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

20%
prescriptions for brand name drugs

Avg: 18%

$67
Average prescription price

Avg: $64

JOHN ROBERTS MD

Interventional Pain Medicine

4,030

$173K

428
183 are 65+

40%
patients receiving schedule two controlled substances

Avg: 38%

59%
patients receiving schedule three controlled substances

Avg: 52%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

10%
prescriptions for brand name drugs

Avg: 18%

$43
Average prescription price

Avg: $64

WESLEY SPRUILL MD

Interventional Pain Medicine

3,919

$187K

674
420 are 65+

27%
patients receiving schedule two controlled substances

Avg: 38%

39%
patients receiving schedule three controlled substances

Avg: 52%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

20%
prescriptions for brand name drugs

Avg: 18%

$48
Average prescription price

Avg: $64

JAMES DARDEN MD

Interventional Pain Medicine

3,723

$169K

285
166 are 65+

44%
patients receiving schedule two controlled substances

Avg: 38%

55%
patients receiving schedule three controlled substances

Avg: 52%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

18%
prescriptions for brand name drugs

Avg: 18%

$45
Average prescription price

Avg: $64

JOHN MARSELLA MD

Interventional Pain Medicine

3,687

$332K

271
88 are 65+

56%
patients receiving schedule two controlled substances

Avg: 38%

41%
patients receiving schedule three controlled substances

Avg: 52%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

24%
prescriptions for brand name drugs

Avg: 18%

$90
Average prescription price

Avg: $64

VICTOR MENDOZA MD

Interventional Pain Medicine

3,636

$201K

211
31 are 65+

65%
patients receiving schedule two controlled substances

Avg: 38%

54%
patients receiving schedule three controlled substances

Avg: 52%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

26%
prescriptions for brand name drugs

Avg: 18%

$55
Average prescription price

Avg: $64

WAYNE COCKRELL M.D.

Interventional Pain Medicine

3,037

$122K

210
78 are 65+

20%
patients receiving schedule two controlled substances

Avg: 38%

66%
patients receiving schedule three controlled substances

Avg: 52%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

10%
prescriptions for brand name drugs

Avg: 18%

$40
Average prescription price

Avg: $64

MARK WILLIS MD

Interventional Pain Medicine

2,533

$111K

223
82 are 65+

36%
patients receiving schedule two controlled substances

Avg: 38%

68%
patients receiving schedule three controlled substances

Avg: 52%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

8%
prescriptions for brand name drugs

Avg: 18%

$44
Average prescription price

Avg: $64

WILLIAM MCRAE M.D.

Interventional Pain Medicine

2,376

$139K

154
66 are 65+

32%
patients receiving schedule two controlled substances

Avg: 38%

41%
patients receiving schedule three controlled substances

Avg: 52%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

18%
prescriptions for brand name drugs

Avg: 18%

$59
Average prescription price

Avg: $64

ROGER KEMP M.D.

Interventional Pain Medicine

1,953

$103K

175
90 are 65+

26%
patients receiving schedule two controlled substances

Avg: 38%

34%
patients receiving schedule three controlled substances

Avg: 52%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

25%
prescriptions for brand name drugs

Avg: 18%

$53
Average prescription price

Avg: $64

DAVID EVANS MD

Interventional Pain Medicine

1,665

$111K

159
101 are 65+

17%
patients receiving schedule two controlled substances

Avg: 38%

55%
patients receiving schedule three controlled substances

Avg: 52%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

20%
prescriptions for brand name drugs

Avg: 18%

$67
Average prescription price

Avg: $64

MICHAEL FLANAGAN MD

Interventional Pain Medicine

1,592

$84.2K

135
53 are 65+

33%
patients receiving schedule two controlled substances

Avg: 38%

52%
patients receiving schedule three controlled substances

Avg: 52%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

22%
prescriptions for brand name drugs

Avg: 18%

$53
Average prescription price

Avg: $64

MATTHEW BARFIELD D.O.

Interventional Pain Medicine

992

$59.1K

190
91 are 65+

60%
patients receiving schedule two controlled substances

Avg: 38%

40%
patients receiving schedule three controlled substances

Avg: 52%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

23%
prescriptions for brand name drugs

Avg: 18%

$60
Average prescription price

Avg: $64

THOMAS YEARWOOD M.D., PHD

Interventional Pain Medicine

944

$72K

215
95 are 65+

27%
patients receiving schedule two controlled substances

Avg: 38%

45%
patients receiving schedule three controlled substances

Avg: 52%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

27%
prescriptions for brand name drugs

Avg: 18%

$76
Average prescription price

Avg: $64

ERIC ROBINSON M.D.

Interventional Pain Medicine

874

$73.7K

161
79 are 65+

38%
patients receiving schedule two controlled substances

Avg: 38%

52%
patients receiving schedule three controlled substances

Avg: 52%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

28%
prescriptions for brand name drugs

Avg: 18%

$84
Average prescription price

Avg: $64

KENNETH VARLEY M.D.

Interventional Pain Medicine

782

$39.8K

109
45 are 65+

29%
patients receiving schedule two controlled substances

Avg: 38%

49%
patients receiving schedule three controlled substances

Avg: 52%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

18%
prescriptions for brand name drugs

Avg: 18%

$51
Average prescription price

Avg: $64

DAVID WALSH M.D.

Interventional Pain Medicine

759

$19.1K

209
110 are 65+

21%
patients receiving schedule two controlled substances

Avg: 38%

67%
patients receiving schedule three controlled substances

Avg: 52%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

8%
prescriptions for brand name drugs

Avg: 18%

$25
Average prescription price

Avg: $64

MEDHA PRADHAN MD

Interventional Pain Medicine

427

$11.6K

107
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 38%

24%
patients receiving schedule three controlled substances

Avg: 52%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 4%

9%
prescriptions for brand name drugs

Avg: 18%

$27
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank